Thyroid Cancer
403
82
113
156
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
44 trials with published results (11%)
Research Maturity
156 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
20 terminated out of 403 trials
88.6%
+2.1% vs benchmark
5%
22 trials in Phase 3/4
28%
44 of 156 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 156 completed trials
Clinical Trials (403)
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Hereditary Risk Factors for Thyroid Cancer
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Progressive Muscle Relaxation for Pain and Quality of Life in Thyroid Cancer
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
DESTINY-PANTUMOUR04
Trop2-targeted immunoPET Imaging of Solid Tumors
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response
Brodalumab in the Treatment of Immune-Related Adverse Events
Ganoderma Spores Modulate the Gut-Brain Axis
Studies on Tumors of the Thyroid